Table 2.
Multivariable regression analysis on fatal outcome | ||||
---|---|---|---|---|
aOR | 95% CI | p-value | ||
Age | ||||
18–45 years | Reference | |||
46–55 years | 3.01 | 0.95 | 9.60 | 0.062 |
56–65 years | 1.72 | 0.56 | 5.33 | 0.344 |
66–75 years | 3.08 | 1.04 | 9.13 | 0.043 |
76–85 years | 3.95 | 1.35 | 11.55 | 0.012 |
> 85 years | 7.34 | 2.45 | 21.99 | < 0.001 |
Gender | ||||
Female | 0.87 | 0.66 | 1.15 | 0.340 |
Male | Reference | |||
Comorbidities* | ||||
Hypertension | 0.98 | 0.67 | 1.37 | 0.897 |
Chronic heart failure | 1.67 | 1.25 | 2.23 | < 0.001 |
Coronary artery disease | 1.41 | 1.05 | 1.89 | 0.021 |
Diabetes mellitus type 2 | 0.97 | 0.73 | 1.28 | 0.810 |
COPD | 1.28 | 0.86 | 1.91 | 0.223 |
Active oncological disease | 1.73 | 1.07 | 2.80 | 0.027 |
Obesity | 1.03 | 0.69 | 1.53 | 0.895 |
Pre-existing dialysis | 1.08 | 0.75 | 1.54 | 0.692 |
Prior immunosuppressive medication* | ||||
Prior immunosuppressive medication | 0.98 | 0.65 | 1.48 | 0.918 |
Multivariable logistic regression on fatal outcome was performed using the imputed data set. Obesity was defined by an indicated Body-Mass-Index > 30 kg/m2. Prior immunosuppressive medication includes an interval of 3 months before SARS-CoV-2 infection, therapy limitation defined as Do-Not-Intubate-, Do-Not-Resuscitate-Orders or the refusal of intensive care, advanced respiratory support as invasive or non-invasive mechanical ventilation or ECMO. aOR: adjusted odds ratio. CI: confidence interval. COPD: chronic obstructive pulmonary disease. ECMO: extracorporeal membrane oxygenation. * No reference level indicated in binary variables